- Home
- Ophthalmology
- OPUS Trial Insights on Lifitegrast for Dry Eye Disease Management
1w3 min read
Medical Article
IntroductionDry eye disease (DED) is a chronic, multifactorial disorder of the ocular surface characterized by tear film instability, ocular surface inflammation, and neurosensory abnormalities, leading to symptoms such as ocular dryness, irritation, discomfort, a...

OPUS Trial Insights on Lifitegrast for Dry Eye Disease Management
Similar Content

ACC, AHA and ESC Recommendations for Heart Failure Management
2323 Reached29 Comments2 Likes

Catheter Ablation for Atrial Fibrillation with HF
691 Reached

Male Complaining of Bilateral Knee Pain and Gait Disturbance
840 Reached5 Comments1 Likes

Study evaluating Effectiveness of Bacillus clausii for Treatment of Rotavirus Infection
1303 Reached4 Comments6 Likes

Safe Ramadan Practices during COVID-19 - WHO Guidance
6556 Reached8 Comments3 Likes
